Morgan Stanley’s IM Cannabis IMCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100
Closed -$139 8391
2025
Q4
$139 Buy
+100
New +$162 ﹤0.01% 7671
2024
Q3
Sell
-1
Closed -$2 7979
2024
Q2
$2 Hold
1
﹤0.01% 7830
2024
Q1
$2 Hold
1
﹤0.01% 7801
2023
Q4
$1 Hold
1
﹤0.01% 7807
2023
Q3
$3 Hold
1
﹤0.01% 7589
2023
Q2
$4 Hold
1
﹤0.01% 7626
2023
Q1
$3 Hold
1
﹤0.01% 7689
2022
Q4
$4 Hold
1
﹤0.01% 7837
2022
Q3
$0 Hold
1
﹤0.01% 7789
2022
Q2
$0 Buy
+1
New +$72 ﹤0.01% 7884
2022
Q1
Sell
-8
Closed -$2K 8032
2021
Q4
$2K Sell
8
-20
-71% -$3.9K ﹤0.01% 7796
2021
Q3
$6K Buy
28
+8
+40% +$2.02K ﹤0.01% 7447
2021
Q2
$6K Buy
20
+17
+567% +$5.61K ﹤0.01% 7342
2021
Q1
$1K Buy
+3
New +$1.47K ﹤0.01% 7349

Other funds holding IMCC

Morgan Stanley's IMCC Position: Q1 2026 in Review

Morgan Stanley sold out of IM Cannabis (IMCC) in Q1 2026, closing a stake of 100 shares — an estimated $139 sold.

Morgan Stanley first reported a position in IMCC in Q1 2021 and held it in 14 quarters. The position peaked at $6K in Q3 2021. 10 funds tracked by Wall St. Rank hold IMCC as of Q1 2026.

  • Morgan Stanley reported no remaining IM Cannabis position as of Q1 2026 after selling out during the quarter.
  • Morgan Stanley sold 100 IM Cannabis shares in Q1 2026, an estimated $139.
  • Morgan Stanley first reported a position in IM Cannabis in Q1 2021 and held it in 14 quarters.
  • Morgan Stanley's IM Cannabis position peaked at $6K in Q3 2021.
  • 10 funds tracked by Wall St. Rank held IM Cannabis as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.